Search Results 381-390 of 15933 for SC

  1. Pasireotide (subcutaneous route, intramuscular route) - Side effects & dosage - Mayo Clinic

    Pasireotide injection is also used for the treatment of acromegaly (a growth hormone disorder) in patients who cannot be treated with surgery. Signifor® is ...

  2. Sports Medicine Research - Meniscus Injury

    Faucett SC, Geisler BP, Chahla J, Krych AJ, Kurweil PR, Garner AM, Liu S, LaPrade RF, Pietzsch JB. Meniscus root repair vs meniscectomy or nonoperative ...

  3. Colon Adenocarcinoma Clinical Trials - Mayo Clinic Research

    This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...

  4. Omalizumab (subcutaneous route) - Mayo Clinic

    Omalizumab injection is used to treat moderate to severe persistent allergic asthma. It is used when a patient's asthma has not been controlled sufficiently on ...

  5. Publications - John J. Lucido, III, Ph.D. - Mayo Clinic

    ... SC, Rule WG, Deufel CL, Foster MG. Development and Dosimetric Characterization of a Customizable Shield for Subtotal Skin Electron Beam Therapy. Adv Radiat ...

  6. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma - Mayo Clinic

    The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed ...

  7. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... [SC] or intramuscular ... at least one 2-week induction regimen of golimumab (one 200 mg SC dose followed by one 100 mg SC dose at least 2 weeks apart); ...

  8. Epigenomics and Spatial Biology Core - Mayo Clinic Research

    Single cell (sc) ATAC-seq. Single-cell ATAC-seq combined with gene expression (scATAC+GEX). Single-cell GEX Flex, a single-cell transcriptome assay for ...

  9. Publications - Laura E. Breeher, M.D., M.P.H. - Mayo Clinic

    ... SC. A Multisite Assessment of Inpatient Safety Event Rates During the Coronavirus Disease 2019 Pandemic. Mayo Clin Proc Innov Qual Outcomes. 2023 Feb; 7 (1): ...

  10. A 2-stage, Phase III Study To Investigate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/​or Subacute Cutaneous Lupus Erythematosus (LAVENDER) - Mayo Clinic

    This study aims to evaluate the efficacy and safety of subcutaneous (SC) anifrolumab versus placebo in adult participants with cutaneous lupus erythematosus ( ...